Table of Content

1. Preface

1.1. Report Scope and Market Segmentation

1.2. Research Highlights


2. Assumptions and Research Methodology

2.1. Assumptions

2.2. Research Methodology


3. Executive Summary

3.1. Global Alcoholic Hepatitis Therapeutics Market Snapshot


4. Market Overview

4.1. Product Overview

4.2. Market Dynamics

4.3. Drivers and Restraints Snapshot Analysis

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.3.4. Key Trends

4.4. Global Alcoholic Hepatitis Therapeutics Market Revenue Projection

4.5. Global Alcoholic Hepatitis Therapeutics Market Outlook


5. Market Outlook

5.1. COVID-19 Pandemic Impact on Global Alcoholic Hepatitis Therapeutics Industry

5.2. Regulatory Scenario, by Region/globally

5.3. Health Care Overview

5.4. Pipeline Analysis

5.5. Epidemiology of Alcoholic Liver Diseases

5.6. Overview of Alcoholic Hepatitis


6. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Treatment

6.1. Introduction

6.2. Global Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment

6.3. Global Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment

6.3.1. Corticosteroids

6.3.2. Hemorrheologic Agents

6.3.3. Anabolic Steroids

6.3.4. Others

6.4. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Treatment


7. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Application

7.1. Introduction

7.2. Global Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application

7.3. Global Alcoholic Hepatitis Therapeutics Market Forecast, by Application

7.3.1. Mild

7.3.2. Severe/Chronic

7.4. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Application


8. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Distribution Channel

8.1. Introduction

8.2. Global Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel

8.3. Global Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel

8.3.1. Hospital Pharmacies

8.3.2. Retail Pharmacies

8.3.3. Online Pharmacies

8.4. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Distribution Channel


9. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Region

9.1. Global Alcoholic Hepatitis Therapeutics Market Scenario, by Country

9.2. Global Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Region

9.3. Global Alcoholic Hepatitis Therapeutics Market Forecast, by Region

9.3.1. North America

9.3.2. Europe

9.3.3. Asia Pacific

9.3.4. Latin America

9.3.5. Middle East & Africa


10. North America Alcoholic Hepatitis Therapeutics Market Analysis

10.1. North America Alcoholic Hepatitis Therapeutics Market Analysis

10.2. North America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment

10.3. North America Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment

10.3.1. Corticosteroids

10.3.2. Hemorrheologic Agents

10.3.3. Anabolic Steroids

10.3.4. Others

10.4. North America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application

10.5. North America Alcoholic Hepatitis Therapeutics Market Forecast, by Application

10.5.1. Mild

10.5.2. Severe/Chronic

10.6. North America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel

10.7. North America Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel

10.7.1. Hospital Pharmacies

10.7.2. Retail Pharmacies

10.7.3. Online Pharmacies

10.8. North America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country

10.9. North America Alcoholic Hepatitis Therapeutics Market Forecast, by Country

10.9.1. U.S.

10.9.2. Canada


11. Europe Alcoholic Hepatitis Therapeutics Market Analysis

11.1. Europe Alcoholic Hepatitis Therapeutics Market Analysis

11.2. Europe Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment

11.3. Europe Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment

11.3.1. Corticosteroids

11.3.2. Hemorrheologic Agents

11.3.3. Anabolic Steroids

11.3.4. Others

11.4. Europe Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application

11.5. Europe Alcoholic Hepatitis Therapeutics Market Forecast, by Application

11.5.1. Mild

11.5.2. Severe/Chronic

11.6. Europe Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel

11.7. Europe Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel

11.7.1. Hospital Pharmacies

11.7.2. Retail Pharmacies

11.7.3. Online Pharmacies

11.8. Europe Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region

11.9. Europe Alcoholic Hepatitis Therapeutics Market Forecast, by Country/Sub-region

11.9.1. U.K.

11.9.2. Germany

11.9.3. France

11.9.4. Spain

11.9.5. Italy

11.9.6. Rest of Europe


12. Asia Pacific Alcoholic Hepatitis Therapeutics Market Analysis

12.1. Asia Pacific Alcoholic Hepatitis Therapeutics Market Analysis

12.2. Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment

12.3. Asia Pacific Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment

12.3.1. Corticosteroids

12.3.2. Hemorrheologic Agents

12.3.3. Anabolic Steroids

12.3.4. Others

12.4. Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application

12.5. Asia Pacific Alcoholic Hepatitis Therapeutics Market Forecast, by Application

12.5.1. Mild

12.5.2. Severe/Chronic

12.6. Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel

12.7. Asia Pacific Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel

12.7.1. Hospital Pharmacies

12.7.2. Retail Pharmacies

12.7.3. Online Pharmacies

12.8. Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region

12.9. Asia Pacific Alcoholic Hepatitis Therapeutics Market Forecast, by Country/Sub-region

12.9.1. Australia & New Zealand

12.9.2. Japan

12.9.3. China

12.9.4. India

12.9.5. Rest of Asia Pacific

13. Latin America Alcoholic Hepatitis Therapeutics Market Analysis

13.1. Latin America Alcoholic Hepatitis Therapeutics Market Analysis

13.2. Latin America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment

13.3. Latin America Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment

13.3.1. Corticosteroids

13.3.2. Hemorrheologic Agents

13.3.3. Anabolic Steroids

13.3.4. Others

13.4. Latin America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application

13.5. Latin America Alcoholic Hepatitis Therapeutics Market Forecast, by Application

13.5.1. Mild

13.5.2. Severe/Chronic

13.6. Latin America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel

13.7. Latin America Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel

13.7.1. Hospital Pharmacies

13.7.2. Retail Pharmacies

13.7.3. Online Pharmacies

13.8. Latin America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region

13.9. Latin America Alcoholic Hepatitis Therapeutics Market Forecast, by Country/Sub-region

13.9.1. Brazil

13.9.2. Mexico

13.9.3. Rest of Latin America


14. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Analysis

14.1. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Analysis

14.2. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment

14.3. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment

14.3.1. Corticosteroids

14.3.2. Hemorrheologic Agents

14.3.3. Anabolic Steroids

14.3.4. Others

14.4. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application

14.5. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Forecast, by Application

14.5.1. Mild

14.5.2. Severe/Chronic

14.6. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel

14.7. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel

14.7.1. Hospital Pharmacies

14.7.2. Retail Pharmacies

14.7.3. Online Pharmacies

14.8. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region

14.9. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Forecast, by Country/Sub-region

14.9.1. GCC Countries

14.9.2. South Africa

14.9.3. Rest of Middle East & Africa


15. Competitive Landscape

15.1. Company Profile

15.1.1. Gilead Sciences, Inc.

15.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.1.1.2. Financial Overview

15.1.1.3. Product Portfolio

15.1.1.4. SWOT Analysis

15.1.1.5. Strategic Overview

15.1.2. Sanofi

15.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.1.2.2. Financial Overview

15.1.2.3. Product Portfolio

15.1.2.4. SWOT Analysis

15.1.2.5. Strategic Overview

15.1.3. Generon Pharmaceutical Technology (Shanghai) Co., Ltd.

15.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)

15.1.3.2. Financial Overview

15.1.3.3. Product Portfolio

15.1.3.4. SWOT Analysis

15.1.3.5. Strategic Overview

15.1.4. Immuron Ltd.

15.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)

15.1.4.2. Product Portfolio

15.1.4.3. SWOT Analysis

15.1.4.4. Strategic Overview

15.1.5. Intercept Pharmaceuticals, Inc.

15.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)

15.1.5.2. Financial Overview

15.1.5.3. Product Portfolio

15.1.5.4. SWOT Analysis

15.1.5.5. Strategic Overview



List of Figures



Figure 01: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) and Distribution, by Region, 2019 and 2030

Figure 02: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, 2018–2030

Figure 03: Market Value Share, by Treatment, 2019

Figure 04: Market Value Share, by Application, 2019

Figure 05: Market Value Share, by Distribution Channel, 2019

Figure 06: Market Value Share, by Region, 2019

Figure 07: Regulatory Approval Process - U.S.

Figure 08: Regulatory Approval Process - Europe

Figure 09: Regulatory Approval Process - Japan

Figure 10: Global Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030

Figure 11: Global Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020–2030

Figure 12: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Corticosteroids, 2018–2030

Figure 13: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hemorrheologic Agents, 2018–2030

Figure 14: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anabolic Steroids, 2018–2030

Figure 15: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2018–2030

Figure 16: Global Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030

Figure 17: Global Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020–2030

Figure 18: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Mild AH, 2018–2030

Figure 19: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Severe/Chronic AH, 2018–2030

Figure 20: Global Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 21: Global Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 22: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2018–2030

Figure 23: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2018–2030

Figure 24: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2018–2030

Figure 25: Global Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Region, 2019 and 2030

Figure 26: Global Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Region, 2020??–2030

Figure 27: North America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 28: North America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020??–2030

Figure 29: North America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030

Figure 30: North America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020??–2030

Figure 31: North America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030

Figure 32: North America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020??–2030

Figure 33: North America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 34: North America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Country, 2019 and 2030

Figure 35: North America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Country, 2020–2030

Figure 36: Europe Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 37: Europe Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020?-–2030

Figure 38: Europe Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030

Figure 39: Europe Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020??–2030

Figure 40: Europe Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030

Figure 41: Europe Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020??–2030

Figure 42: Europe Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 43: Europe Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 44: Europe Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 45: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 46: Asia Pacific Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020??–2030

Figure 47: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030

Figure 48: Asia Pacific Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020??–2030

Figure 49: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030

Figure 50: Asia Pacific Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020??–2030

Figure 51: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 52: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 53: Asia Pacific Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 54: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 55: Latin America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020??–2030

Figure 56: Latin America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030

Figure 57: Latin America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020??–2030

Figure 58: Latin America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030

Figure 59: Latin America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020??–2030

Figure 60: Latin America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 61: Latin America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 62: Latin America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 63 Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 64: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020??–2030

Figure 65: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030

Figure 66: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020??–2030

Figure 67: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030

Figure 68: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020??–2030

Figure 69: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 70: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 71: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 72: Gilead Sciences, Inc., Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2019

Figure 73: Gilead Sciences, Inc., Breakdown of Net Sales, by Region, 2019

Figure 74: Gilead Sciences, Inc., R&D Intensity (%) - Company Level or Segment Level, 2016–2019

Figure 75: Sanofi, Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 76: Sanofi, Breakdown of Net Sales, by Business Segment, 2019

Figure 77: Sanofi, Breakdown of Net Sales, by Region, 2019

Figure 78: Immuron, Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 79: Immuron, R&D Expenses - Company Level, 2016–2019

Figure 80: Intercept Pharmaceuticals, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 81: Intercept Pharmaceuticals, Inc., R&D Expenses - Company Level, 2016–2019


List of Tables



Table 01: Alcohol, total per capita (15+) consumption (in liters of pure alcohol) with 95%CI, by Country, 2016

Table 02: Epidemiology of Covid-19 Country/Sub-region

Table 03: Gross Domestic Product (GDP), by Country, 2014-2017

Table 04: Pipeline Analysis of Alcoholic Hepatitis Therapeutics

Table 05: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2018–2030

Table 06: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 07: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 08: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 09: North America Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Treatment, 2018–2030

Table 10: North America Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Application, 2018–2030

Table 11: North America Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 12: North America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 13: Europe Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) Forecast, by Treatment, 2018–2030

Table 14: Europe Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) Forecast, by Application, 2018–2030

Table 15: Europe Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 16: Europe Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 17: Asia Pacific Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Treatment, 2018–2030

Table 18: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 19: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 20: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 21: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2018–2030

Table 22: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 23: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 24: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 25: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2018–2030

Table 26: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 27: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 28: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030